CLDN3 and ovarian cancer: On the other hand, Claudin-3 and -4 are frequently elevated in various cancers including pancreatic ductal adenocarcinoma, prostate, uterine, ovarian cancer [53] and breast cancer [54] while hepatocellular and renal carcinomas expressed lower levels of claudins-4 and -5 [55].